**What's Known**

Previous studies regarding the anti-diabetic properties of *Urtica dioica* were limited to different extracts of this plant.In spite of high consumption of *U. dioica* distillate (aragh gazaneh) by diabetic patients in Iran, there is no scientific report about the effectiveness of this drink.

**What's New**

Administration of *U. dioica* distillate in STZ-induced diabetic rats lowers the blood glucose level and recovers the insulin level and pancreatic islet volumes via β-cell regeneration with no significant effect on healthy normal rats in this regard.

Introduction {#sec1-1}
============

Diabetes is a widespread endocrine disorder characterized by hyperglycemia resulting from flawed insulin discharge, resistance to insulin action or both.^[@ref1],[@ref2]^ The statistics show that 30 million people were diagnosed with diabetes worldwide in 1985 and it is predicted by the World Health Organization that, at the current rate, there will be 300 million by the year 2025.^[@ref3]^ Despite substantial improvement in the management of diabetes by hypoglycemic drugs, search for newer drugs is continuing because the current anti-diabetic agents have several restrictions such as lack of efficacy and undesirable side effects.^[@ref4]^ It is stated that the plant materials derivatives have provided the models for 50% of the Western drugs.^[@ref5]^ For example, metformin was developed based on a biguanide compound from the anti-diabetic herb known as French liliac, and is now the first-line drug for type II of diabetes.^[@ref4]^ Among medicinal plants, more than 1,200 have been reported as remedies for diabetes.^[@ref4]^

According to WHO, more than 80% of the world's population relies on traditional and herbal medicine for their medical disorders.^[@ref5]^ Herbal drug preparations mostly include extraction, fractionation, purification, concentration, fermentation, and distillation.^[@ref6]^ The most common is in the form of plant extracts, which are widely studied.^[@ref7]^ Herbal and/or plant distillates are currently being used in Egypt, Turkey, and substantially in Iran, where it is locally called "aragh" or "araq". According to the literature, it is also known as herbal/essential/floral water, hydrolate, and hydrosol. There are few reports about the actual chemical components of the volatile compartment of some plant/herb, including *Phoenix dactylifera L*. (Tarooneh),^[@ref8]^ *Operculina turpethum* (Turbad),^[@ref9]^ and rose water (Golāb).^[@ref10]^ They showed that these distillates contained essential oil compounds consisting of organic acids and some other water soluble and volatile plant components.

*Urtica dioica* has been widely used in folk medicine as an anti-hyperglycemic agent to treat diabetes mellitus.^[@ref11]^ *Urtica* is a genus of flowering plants in the family *Urticaceae*. Many species have stinging hairs and may be called nettles or stinging nettles, although the latter name is particularly used for *Urtica dioica*.^[@ref12]^ A variety of pharmacological effects have been demonstrated for nettle leaves, including insulin secretagogue^[@ref13]^ and insulin mimetics.^[@ref14]^ Others also reported that *U. dioica* extract has proliferation potency^[@ref15]^ and alpha-glucosidase inhibitory activities.^[@ref16]^ The whole plant is also used in folk medicine to treat allergies, kidney stones, burns, anemia, rashes, and internal bleeding.^[@ref5],[@ref6]^ Moreover, there are some other studies indicating that the consumption of *U dioica* hydroalchoholic extract has no hypoglycemic effect and/or β-cell regeneration in diabetic rats.^[@ref17]^

Iran is one of the ancient countries in the utilization of medicinal plants for the treatment and prevention of disorders. Because of the wide diversity of climate and geographical conditions of Iran, many different medicinal species are under cultivation.^[@ref18]^ In the south-center of Iran, the city of Shiraz, the most popular system used for home remedies and regaining well-being has been the use of plant distillates since ancient times. The distillate obtained from *U. dioica* is being widely used as a non-alcoholic drink among the Iranian diabetic patients. Therefore, the aim of the current study was to evaluate the anti-diabetic properties of *Urtica dioica* distillate (UD). With regard to the fact that the size and number of Langerhans islets correlate with pancreatic endocrine function, the serum insulin and blood glucose in streptozotocin (STZ)-induced diabetic rats, as well as the structure of pancreatic islets, were assessed. Briefly, this survey was designed to answer the following questions: How much does the serum insulin and blood glucose change in diabetic rats and if their treatment with UD recovers these changes? How much does the volume of pancreas as a whole, the Langerhans islets, and the number and volume of beta cells change in diabetic rats and if their treatment with UD recovers the changes?

Materials and Methods {#sec1-2}
=====================

Preparation of Urtica Dioica Distillate {#sec2-1}
---------------------------------------

*Urtica dioica* plant was collected from the farms around Sari, a city in the north of Iran, and then authenticated by Sari Agricultural Sciences and Natural Resources University. For the preparation of 1 liter of UD, 3.75 kg fresh plants were harvested, washed, transferred into the upper partition of steam boiler, and added with 1.5 liters of water. The procedure was performed as described previously by Seghatoleslam et al.^[@ref19]^ Keeping the heat of the boiling water constant at 65-70 ºC, the steam from *U. dioica* plant was cooled in the condenser duct and the resulting UD (called aragh gazaneh) was collected in a light-protected bottle and conserved at 4 ºC until use.

Experimental Rats {#sec2-2}
-----------------

A total of 48 Sprague-Dawley male rats (4-5 weeks of age, 200-250 g of weight) were obtained from the Animal Center of Shiraz University of Medical Sciences and randomly distributed into 6 groups, each including 8 rats. Distilled water (DW: 12.5 ml/kg/day), *U. dioica* distillate (UD: 12.5 ml/kg/day), and glibenclamide (0.6 mg/kg/day) were administered via intragastric gavage. Insulin (3 units of protamine insulin, twice a day) was injected subcutaneously. The experiments were performed for 4 weeks. Experimental groups were designed as follows:

Group I: Non-diabetic plus DW

Group II: Non-diabetic plus UD

Group III: Diabetic plus DW

Group IV: Diabetic plus UD

Group V: Diabetic plus insulin

Group VI: Diabetic plus glibenclamide

All protocols of the study were approved by the Institutional Animal Ethics Committee of Shiraz University of Medical Sciences (Shiraz, Iran). The animals were kept in a temperature-controlled condition (24±2 ºC) with a 12-h light/dark alternating cycle and free access to water and standard diet.

Diabetes was induced in overnight-fasting rats by a single intraperitoneal (ip) injection of streptozotocin (STZ, Sigma chemical company, St. Louis, MO, USA) in a dose of 50 mg/kg. STZ was dissolved in citrate buffer as the vehicle (0.1 M, pH 4.5) immediately before use. The rats in groups I and II received only the vehicle. Fasting blood glucose (FBS) levels were determined 72 h after STZ injection with a glucometer in the blood drawn from the tail vein. Diabetes was confirmed in the rats with FBS above 250 mg/dl (13.8 mM).

FBS of the animals was measured once every 9 days (zero, 9th, 18th, and 27th) using blood from the tail. At the end of the experiments, the rats in the fed state were anesthetized by CO~2~, the blood samples were obtained from the heart, and the rats were then sacrificed. The sera were separated to measure the insulin levels. The pancreas was gently dissected out, cleaned from fat and connective tissues, weighed, and kept in formalin buffer (pH=7.4) until use.

Biochemical Parameters {#sec2-3}
----------------------

Fasting blood sugar measurement

FBS was measured as mentioned above by Accu-Chek Glucometer (Accu-Chek^®^ Active, Roche Diagnostics GmbH, Hannheim, Germany) and expressed in terms of mg/dl.

Measurement of serum insulin

Serum insulin levels were measured in the experimental rats except for the groups V and VI. ELISA method was applied using a kit from Mercodia Corporation (Uppsala, Sweden).

Stereological Parameters {#sec2-4}
------------------------

Estimation of pancreas volume

Primary volume (Vprimary) of the pancreas was estimated according to Scherle's immersion method.^[@ref20],[@ref21]^ The isotropic uniform random (IUR) slabs of the pancreas were obtained with the orientator method.^[@ref21]^ Two circular pieces (3 mm diameter) were punched out from two random slabs.^[@ref21]^ All the slabs and the circular pieces were molded in a paraffin cube. After tissue sectioning, processing, and staining of the slabs and pieces, the area of the circular pieces was measured. The modified Gomori's aldehyde-fuchsin, according to Bangle's method was used to stain the tissue sections.^[@ref22]^ Two sections including 4 μm and 25 μm were cut from the slabs. The degree of shrinkage "D(sh)" was estimated using the following formula:

D(sh)=1--(AA/AB)^1.5^

Where AA and AB are the areas of each circular piece of the pancreas after and before processing, sectioning, and staining, respectively.

Estimation of volume density of the pancreatic islets

The 4 μm thickness microscopic slides were analyzed by a video microscopy system using the point-counting method. The following formula was used to estimate the volume density of the islets:

Vv(islet, pancreas)=P(islet)/P(reference)

Where the respective P (islet) and P (reference) are the numbers of the test-points hitting the islet profile and the reference space.

Then, the final islet volume "V(islets)" was estimated according to the following formula:

V(islets)=Vv(islet, pancreas)×V(primary)

Numerical Density of β-Cells

β-cells were counted according to the optical disector method, an oil immersion objective lens (60×oil, numerical aperture 1.4 at a final magnification of 2000X).^[@ref23]^ The following formula was also used to estimate the numerical density of the cells "NV(cells/islets)":

NV(cells/islets)=\[ΣQ/(Σp×(*a/f*)×h)\]×(t/BA)

Where "ΣQ" is the number of the β-cells counted in all the dissectors, "Σp" is the total number of the counted frames, "*a/f*" is the area of the counting frame (here was 184 μm^[@ref2]^), "h" is the height of the optical disector (here was 15 μm), "BA" is the microtome block advance to cut the block (here was 25 μm), and "t" is the mean of final section thickness (24.3 μm on average).^[@ref23]^ In order to determine the total number of β-cells "N(cells)", the following formula was used:

N(cells)=NV(cells/islets)×V(islets)×D(sh)

Estimation of beta cells volume

The number-weighed mean volumes of the cells were estimated using "nucleator". The cells were tested using disector method. The intercept length (l~n~) from the center of β-cell nucleus to cell membrane was measured in four directions.^[@ref24]^ The following formula was used for the estimation of the nucleus or cell volume:
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Statistical Analysis {#sec2-5}
--------------------

Statistical analysis and graphic design were performed by SPSS (version 23.0) and GraphPad Prism 5 software (San Diego, CA, USA). For comparisons between groups Kruskal--Wallis, repeated measurements and Mann-Whitney U test (P\<0.05 was considered as a significant difference) were used. The stereological values were presented as dot plots.

Results {#sec1-3}
=======

Effect of UD on Blood Glucose Level {#sec2-6}
-----------------------------------

FBS levels of the experimental rats during 4-week treatment are presented in [figure 1](#F1){ref-type="fig"}. As shown, the rats in the diabetic group receiving water (group III) displayed a significant increase (P\<0.001) in the FBS levels compared to the non-diabetic groups (I and II). Obviously, the treatment of diabetic rats with UD significantly decreased (P\<0.001) the blood glucose compared to the control diabetic rats while displaying a significant difference with the normal rats. Insulin injection also reduced FBS significantly (P\<0.001) when compared to diabetic rats and normalized it on day 27. Glibenclamide also lowered FBS levels, but not significant when compared to the control diabetic rats. Furthermore, no significant differences were observed for FBS between the normal rats in groups I and II.

![Comparison of fasting blood sugar in 6 groups of experimental rats (n=8) during 27 days. Data represent the average of the results of all rats in each group. \*Significant difference between non-diabetic plus DW group vs. all groups; ●-Significant difference between diabetic plus DW group vs. all groups (P\<0.05).](IJMS-43-174-g001){#F1}

Effect of UD on Serum Insulin Levels {#sec2-7}
------------------------------------

As shown, the serum insulin levels decreased significantly (P=0.01) in the diabetic rats on day 27 compared to the non-diabetic rats ([figure 2](#F2){ref-type="fig"}). According to our data, in the diabetic animals, treatment with UD remarkably (P=0.03) increased the serum insulin levels when compared to the diabetic rats, but there was still a significant difference in comparison with non-diabetic rats (P\<0.001). No significant changes in the serum insulin levels were observed in the non-diabetic plus UD compared to the non-diabetic plus DW rats ([figure 2](#F2){ref-type="fig"}).

![Effect of UD on serum insulin levels of experimental rats (n=8) on day 27. Data are represented as mean±SEM. Kruskal-Wallis was used for comparisons between groups. Bars (•, \*, ×) indicate significant (P\<0.05) differences between groups.](IJMS-43-174-g002){#F2}

Effect of UD on Stereological Parameters {#sec2-8}
----------------------------------------

The mean islet volume, mean β-cell numbers, and mean β-cell volumes were reduced by 37%, 31%, and 62%, respectively, in the diabetic plus DW animals compared to the non-diabetic plus DW rats ([figure 3](#F3){ref-type="fig"}). The volume of pancreas revealed no significant changes in the experimental rats ([figure 3A](#F3){ref-type="fig"}). In the diabetic rats treated with UD, the volumes of the islets were approximately the same as non-diabetic plus DW rats ([figure 3B](#F3){ref-type="fig"}). Interestingly, there was no difference between the β-cell numbers in diabetic plus UD and non-diabetic plus DW rats, thus the number of β-cells was recovered in diabetic plus UD ([figure 3C](#F3){ref-type="fig"}). However, the mean β-cells volume was not recovered after UD treatment in diabetic rats ([figure 3D](#F3){ref-type="fig"}).

![The estimated parameter using stereological methods in 6 groups of experimental rats (n=8). The dot plots show the total volume of the pancreas (A), absolute volume of the islet (B), total number of the β-cells (C), and mean β-cells volume (D). Each dot represents an animal in different groups. The significant differences are indicated in the figures.](IJMS-43-174-g003){#F3}

Qualitative histological examinations are also presented in [figure 4](#F4){ref-type="fig"}. Lower β-cells number was seen in the diabetic plus DW (C) in comparison with non-diabetic plus UD group (A and B). In the diabetic plus UD (D) group, the number of β-cells was higher than diabetic plus DW (D). There was no increase in the β-cells number of rats in diabetic plus insulin (F) and diabetic plus glibenclamide (E) groups in comparison to the diabetic plus DW group (C).

![Light microscopic examination of pancreatic islets dissected from the experimental rats. Photomicrographs represent non-diabetic plus DW (A), non-diabetic plus UD (B), diabetic plus DW (C), diabetic plus UD (D), diabetic plus glibenclamide (E), and diabetic plus insulin (F). The β-cells stained with Gomori's aldehyde fuchsin in which nucleus and cytoplasm (contained granules) are shown with black and white arrows, respectively.](IJMS-43-174-g004){#F4}

Discussion {#sec1-4}
==========

Diabetes is a metabolic disorder of the endocrine system. The spread of this disease around the world is a serious threat to human health. The side effects of chemical drugs and population growth, increase the need for effective medication and a change in the pattern of drug use.^[@ref1]-[@ref4]^ Medicines based on medicinal plants are the most common unconventional medical treatments that have been used since the ancient times in traditional Iranian medicine (TIM).^[@ref9],[@ref11]^ The distillates prepared from different plant species (aragh) are known as common beverages in different parts of Iran. They are widely being used by people to treat health problems. Although a lot of reports emphasize the anti-diabetic effects of nettle extract, the anti-hyperglycemic properties of its hydro-distillate or aragh has not yet been studied.^[@ref11]^ To evaluate the current beliefs on the usefulness of UD for the treatment of diabetes in folk medicine, we performed a series of experiments using STZ-induced diabetic rat model.

Streptozotocin (STZ), used in laboratory animals to induce type 1 diabetes, is a toxic glucose analogue which irreversibly destroys pancreatic β-cells. Hyperglycemia is the clear symptom of STZ-induced diabetes caused by destroying pancreatic islets, reduction of β-cells' mass, and its insulin content.^[@ref23]^ The mechanism of action of STZ on rodent β--cell is related to the uptake of STZ by β-cells and consequent DNA strand break causing a lethal depletion of cellular nicotinamide adenine dinucleotide (NAD^+^) and ATP.^[@ref25]^

The results of the present study showed that UD reduces FBS and recovers the insulin levels during 4 weeks of administration in STZ diabetic rats. While the injection of insulin normalized FBS level in diabetic rats, glibenclamide as the inducer of insulin secretion from β--cells^[@ref26]^ did not significantly reduce the blood sugar in diabetic animals; indicating that the secreted insulin from the remaining β-cells was not enough for blood sugar normalization. Interestingly, the consumption of UD resulted in a significant reduction of FBS in diabetic rats as a result of increased insulin level. Although UD was unable to normalize the blood sugar, its hypoglycemic effect on STZ-diabetic rats was confirmed using stereological studies. The results of this part indicated that UD could recover the pancreatic damage by regenerating β--cells and increasing the serum insulin level. Our findings are consistent with some other reports about anti-hyperglycemic activity^[@ref13]-[@ref15],[@ref27]^ and β-cell regeneration potency of *U. dioica* extract.^[@ref18]^ Ranjbari et al. showed that the administration of STZ-induced diabetic rats by different doses of *U. dioica* aqueous extracts with swimming activity during the 4 weeks decreased the serum glucose level and insulin resistance, and increased insulin sensitivity significantly. Also, the regeneration of pancreatic β-cells was seen in the treated rats.^[@ref28]^ Gaballu et al. showed that Peganum harmala, Rhus coriaria, and *U. dioica* extracts, especially their combination, has significant anti-diabetic, hypolipidemic, liver, and renal damage recovering effects.^[@ref29]^

Some studies showed that *U. dioica* extract had an insulin secretagouge effect that is related to the proliferation and regeneration activity characteristics.^[@ref14],[@ref15]^ Some others revealed that antidiabetic activities of this extract was related to the alpha glucosidase inhibitor activity, inhibition of the absorption of glucose from intestine,^[@ref13],[@ref18]^ and also the improvement of glucose tolerance.^[@ref30]^ Golalipour et al. also revealed that *U. dioica* extract has antioxidant activities and free radical scavenger properties.^[@ref31]^ Qujeq et al. suggested the anti-inflammatory effect of *U. dioica* extract^[@ref32]^ and Namazi et al. investigated its effect on insulin sensitivity and anti-inflammatory marker in patients with type 2 diabetes.^[@ref33]^ They showed that *U. dioica* extract decreased some inflammatory factors and suggested a protective role for cardiovascular disease in patient with type 2 diabetes.^[@ref32]^

Moore et al. showed that *U. dioica* extract does not have a potential health risk and suggested that daily consumption of herbal distillates and decoctions at the indicated doses poses no significant health risk to a normal adult.^[@ref6]^ Interestingly, in a parallel study from our lab, we found no toxic effects on the rat kidney and liver under experimental conditions (data not shown).

In spite of the existence of many reports indicating anti-diabetic properties of *U. dioica*, the results of two controversial studies led to different conclusions. One has claimed that *U. dioica* consumption has no effect on blood glucose and β-cells regeneration in diabetic rats.^[@ref18]^ The other study has asserted that the methanolic extract of nettle aerial parts is unable to increase insulin and C-peptide secretion from the culture of rat pancreatic β-cells.^[@ref34]^ These inconsistencies could be due to the differences in the cultivation conditions, the climate, and the soil which affect plant's properties.^[@ref35]^

Although many studies have proven the anti-diabetic activities of *U. dioica* extract, the details of the actual anti-diabetic mechanism is still unknown. One has shown that this activity of the extract is related to the active component of the *U. dioica* leaves such as flavonoids, peptides, and coxamarins.^[@ref31]^ Some others discussed the presence of numerous different phytochemicals of ethanolic, petroleum ether, chloroform, and methanolic extract of *U. dioica*.^[@ref7],[@ref36]^

Due to the lack of information about the composition of UD, a parallel study in our laboratory was performed. We examined 23 elements based on their roles in the prevention or progression of diabetes. Our results (unpublished) indicated that the distillate of *U. dioica* is rich in macronutrients such as Mg, Ca, Si, and K and also contained microelements including Zn, Cu, Fe, Cr, Mn, Mo, and V which are active components exerting anti-diabetic activities.^[@ref37],[@ref38]^ We also found that this distillate contained numerous (about 89) bioactive compounds belonging to the various classes of terpens, polyphenols, flavonoids, etc. (unpublished). These phytochemicals included secondary metabolites such as limonene, thymol, eugenol, pulegone, and eucalyptol. All these bioactive compounds have antioxidant activity and could protect the cells against oxidative stress. These components have anti-inflammatory, anti-carcinogenic, and anti-diabetic therapeutic effects as well.^[@ref39]^ The effect of UD on the other biochemical parameters such as lipid profile and its potential antioxidant activity are under examination in a joint project.

Despite the tremendous use of many herbal distillates as practical therapeutic interventions in Iranian folk medicine, related pharmaceutical research is largely neglected by medical scientists. It must be noted that few evidences exist for the safety problem associated with the use of herbal/plant distillates. One has claimed that herbal ingredients may contain byproducts such as methanol that possess pharmacological effects as the result of boiling and evaporating woody parts of the plants.^[@ref40]^ Furthermore, potential complications associated with the industrial preparation, standardization, used dosages, and quality control may make it less applicable in comparison to modern pharmaceuticals. However, there is relatively little known regarding efficacy, stability, and safety issues in herbal distillates use, which is a major concern for consumers. The massive use of herbal distillates makes it increasingly important to monitor the progress of the clinical literature and aid practitioners in advising their patients.

Conclusion {#sec1-5}
==========

A 28-day oral UD treatment in STZ-diabetic rats improved hyperglycemia by partially restoring the plasma insulin and lowering fasting blood glucose. This action was through proliferative activity of UD in preventing the islets' atrophy and increasing β-cell numbers. Due to the beneficial effects and less/lack of toxic side effects of UD, it could be recommended as a drug supplement for reducing blood sugar in diabetic patients. However, in those who drink UD and receive anti-diabetic drug simultaneously, physicians should accordingly pay attention to the drug dose in proportion to avoid undesired complications.
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